In near future, it would be interesting to find whether overall CRT or CALR levels in melanoma are predictive of clinical responses to ICD or immunotherapy and/or regulate overall levels/spatial distribution of CD8+ T cell-infiltrates. The gene discussed is CALR; the disease is melanoma.